Results 71 to 80 of about 101,082 (154)

Improving of pelB-Secreted MPT64 protein released by Escherichia coli BL21 (DE3) using Triton X-100 and Tween-80. [PDF]

J Adv Pharm Technol Res, 2022
Kusuma SAF, Subroto T, Parwati I, Rukayadi Y, Fadhlillah M, Pardede RM, Berlian AV, Sabila G.   +7 more
europepmc   +1 more source

Comparative evaluation of E. coli expression systems for soluble hScFv-IL-17A with an unpaired CDR-L3 cysteine

Journal of Genetic Engineering and Biotechnology
This study systematically evaluated Escherichia coli (E. coli) expression systems for the production of a humanized single-chain variable fragment targeting interleukin-17A (hScFv-IL-17A).
Weeraya Thongkum, Kanokporn Sornsuwan, Thanathat Pamonsupornwichit, Anuwat Weechan, Natsima Viriyaadhammaa, Kanchanok Kodchakorn, Chatchai Tawapiwatana   +6 more
doaj   +1 more source

Tailoring the evolution of BL21(DE3) uncovers a key role for RNA stability in gene expression toxicity. [PDF]

Commun Biol, 2021
Heyde SAH, Nørholm MHH.
europepmc   +1 more source

Safety of 6'-sialyllactose (6'-SL) sodium salt produced by derivative strains of Escherichia coli BL21 (DE3) as a novel food pursuant to Regulation (EU) 2015/2283. [PDF]

EFSA J, 2022
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Frenzel T, Heinonen M, Marchelli R, Neuhäuser-Berthold M, Poulsen M, Prieto Maradona M, Schlatter JR, van Loveren H, Colombo P, Noriega Fernández E, Knutsen HK.   +28 more
europepmc   +1 more source

Protein Expression Using BL21(DE3), Large Scale (C2527) v1

, 2014
This is the protocol for a large-scale Protein Expression Using BL21(DE3) Competent E. coli cells(C2527).
openaire   +1 more source

Safety of lacto-N-tetraose (LNT) produced by derivative strains of Escherichia coli BL21 (DE3) as a Novel Food pursuant to Regulation (EU) 2015/2283. [PDF]

EFSA J, 2022
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Frenzel T, Heinonen M, Marchelli R, Neuhäuser-Berthold M, Poulsen M, Prieto Maradona M, Schlatter JR, van Loveren H, Colombo P, Noriega Fernández E, Knutsen HK.   +28 more
europepmc   +1 more source

Construction, expression, and in vitro assembly of virus-like particles of L1 protein of human papillomavirus type 52 in Escherichia coli BL21 DE3. [PDF]

J Genet Eng Biotechnol, 2022
Mustopa AZ, Meilina L, Irawan S, Ekawati N, Fathurahman AT, Triratna L, Kusumawati A, Prastyowati A, Nurfatwa M, Hertati A, Harmoko R.   +10 more
europepmc   +1 more source

Expression and Functional Analysis of the Argonaute Protein of Thermus thermophilus (TtAgo) in E. coli BL21(DE3). [PDF]

Biomolecules, 2021
Xing J, Ma L, Cheng X, Ma J, Wang R, Xu K, Mymryk JS, Zhang Z.   +7 more
europepmc   +1 more source

Safety of 3-fucosyllactose (3-FL) produced by a derivative strain of Escherichia coli BL21 (DE3) as a Novel Food pursuant to Regulation (EU) 2015/2283. [PDF]

EFSA J, 2022
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, Bohn T, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Pelaez C, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Cubadda F, Frenzel T, Heinonen M, Marchelli R, Neuhäuser-Berthold M, Poulsen M, Prieto Maradona M, Schlatter JR, van Loveren H, Colombo P, Noriega Fernández E, Knutsen HK.   +28 more
europepmc   +1 more source

Critical Role of 3'-Downstream Region of pmrB in Polymyxin Resistance in Escherichia coli BL21(DE3). [PDF]

Microorganisms, 2021
Xu F, Hinenoya A, Zeng X, Li XP, Guan Z, Lin J.   +5 more
europepmc   +1 more source